Fig. 1
From: Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
Cardiac response to exercise from cardiopulmonary exercise testing. First cardiopulmonary exercise test almost one year after therapy for Acute Myeloid Leukemia showed a drop in systolic blood pressure throughout exercise (a) and limitations in oxygen uptake (a) and heart rate (b). Four years after therapy for Acute Myeloid Leukemia and continuous competitive exercise training showing a tremendous improved blood pressure (c), oxygen and heart rate response to exercise (d)